MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by mrmarket1on Jan 08, 2019 6:47pm

52 Views

Post# 29203076

RE:RE:RE:parole officer watching

a lot of thought put into copying DEC.25 news release so that they could release it again today ---Didn't even delete the reference to quarterly Dec 28 release ---Real slackers

---- The Company does not anticipate any delay in filing its quarterly financial statements, management’s discussion and analysis, and the related officer certifications for the first financial quarter FY2019. reported on Dec 28 2018 --

i am surprised the company hasn't yet been presented with some form of litigation involving shareholders rights over the past 5 years or more

Bullboard Posts

Gold vs. bitcoin, where should you invest?